Latest Press Releases | MSF Access

Latest Press Releases

Press release |

08 December 2016

MSF Access Campaign names new Executive Director

2 min

Celumusa Hlatswako, an MSF mobile counselor, visits Winile, 39, XDR-TB patient & HIV-positive. They use sign language to communicate because Winile went deaf due to the side effects of the treatment. Matsapha airport, Manzini Region, Swaziland.

Photograph by Alexis Huguet

Press release |

05 December 2016

Intellectual property and trade

RCEP trade deal negotiators must reject terms that would harm access to medicines

4 min

Kulsoom is 20 years old. She has just completed his treatment against hepatitis C and is now cured from the disease.

Photograph by Sa'adia Khan

Press release |

14 November 2016

Intellectual property and trade

MSF responds to latest Access to Medicines Index rankings

In June and July 2016 MSF has been conducting vaccination campaigns in several refugee camps and settlements in Greece, targeting more than 4,600 children under fifteen years of age. This campaign aims at protecting refugee children with 10 antigens and preventing diseases such as pneumonia, which is the leading cause of childhood death. MSF calls on Pfizer and GSK to drop the price of the pneumonia vaccine (PCV) for governments and humanitarian organizations in emergency contexts.

Photograph by Sophia Apostolia

Press release |

14 November 2016

Vaccines

MSF welcomes Pfizer’s pneumonia vaccine price reduction for children in humanitarian emergencies

In New York, on Word Pneumonia Day 2015 (Nov 12), MSF volunteers attempted to deliver more than $17 million of fake cash - the equivalent of one day of profits from the pneumonia vaccines for Pfizer globally - to Pfizer's CEO Ian Read. The same day, MSF launched a global petition to ask Pfizer and GlaxoSmithKline (GSK) to reduce the price of the pneumococcal vaccine to $5 dollars per child (for all three doses) in developing countries. Photograph by Edwin Torres

Photograph by Edwin Torres

Press release |

11 November 2016

Vaccines

Breaking news: Pfizer drops the price of the pneumonia vaccine for humanitarian organizations

Simphiwe holds his first delamanid tablets, which have now been included into his treatment regimen for XDR-TB, October 2016.

Photograph by Sydelle Willow Smith

Press release |

26 October 2016

MSF reports on use of the new TB drugs bedaquiline and delamanid

MSF treats more than 200,000 people worldwide for HIV and 97 percent of the antiretrovirals are quality, affordable generics from India. Here, an MSF doctor in Kenya consults one MSF’s thousands of HIV+ patients under treatment.

Photograph by Olga Victorie

Press release |

14 October 2016

Intellectual property and trade

In lead-up to RCEP trade deal negotiations in China, MSF urges countries not to trade away access to medicines

TB doctor Irma Davitadze at work at the Regional Center of Infectious Pathology, AIDS and Tuberculosis in Batumi, a beach resort town on the Black Sea. MSF has worked here since 2014. Photograph by Daro Sulakauri

Photograph by Daro Sulakauri

Press release |

13 October 2016

MSF response to 2016 WHO Global TB Report